Cai Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cai Li has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Xin-Wei He
Department of Neurology, Taizhou Hospital, Wenzhou Medical University, Zhejiang, China
2 shared publications Bohuai Yu
The First School of Medicine, School of Information and Engineering, Wenzhou Medical University, Wenzhou, Zhejiang, China, wmu.edu.cn
1 shared publication- Chen-Ling Lv
Department of Neurology, Taizhou Hospital, Affiliated Hospital of Wenzhou Medical University, Taizhou, Zhejiang, PR China
1 shared publication - Chun-Qiang Xu
Department of Neurology, Taizhou Hospital, Affiliated Hospital of Wenzhou Medical University, Taizhou, Zhejiang, PR China
1 shared publication - Dan Yu
Department of Neurology, Taizhou Hospital, Affiliated Hospital of Wenzhou Medical University, Taizhou, Zhejiang, PR China
1 shared publication - En Wang
Department of Neurology, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1) , e7919308
The Mediating Factor of Immune Cell in the Causal Relationship Between Cardiovascular Disease‐Related Plasma Proteins and Parkinson’s Disease: A Network Mendelian Randomization Analysis
Background: Cardiovascular diseases (CVDs) and their associated plasma proteins exhibit significant correlations with immunity and Parkinson’s disease (PD). However, the specific contributions to the risk of developing PD remain unclear. This study aims to investigate the potential causal relationship between CVD‐related plasma proteins and the risk of PD and explore the significant mediating role of immune cell phenotypes. Methods: Using publicly available genetic data, we conducted Mendelian randomization (MR) analysis using the inverse variance weighting method to explore the causal relationship between 83 CVD‐related plasma proteins and PD. Various MR analysis models were employed for sensitivity analysis. Concurrently, we utilized bioinformatics methods such as protein–protein interaction networks and pathway enrichment analysis to investigate the potential associations between CVD‐related plasma proteins and PD‐related genes. Finally, we employed a mediator MR design to identify the mediating effects of 731 immune cell phenotypes in the onset of PD. Results: Elevated levels of Fas cell surface death receptors ( p = 0.015) and nerve growth factor ( p = 0.026) are associated with a reduced risk of PD, while increased levels of thrombomodulin ( p = 0.028) are a risk factor for PD. Four immune phenotypes play a significant mediating role in the association between CVD‐related proteins and the pathogenesis of PD. Sensitivity analysis indicates that the results are robust. Conclusions: Our study elucidates the close genetic association between CVD‐related plasma proteins and PD and identifies the significant mediating role of immune cells, thereby providing valuable insights for future research and clinical applications.
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1) , e7919308
Open AccessThe Mediating Factor of Immune Cell in the Causal Relationship Between Cardiovascular Disease‐Related Plasma Proteins and Parkinson’s Disease: A Network Mendelian Randomization Analysis
Background: Cardiovascular diseases (CVDs) and their associated plasma proteins exhibit significant correlations with immunity and Parkinson’s disease (PD). However, the specific contributions to the risk of developing PD remain unclear. This study aims to investigate the potential causal relationship between CVD‐related plasma proteins and the risk of PD and explore the significant mediating role of immune cell phenotypes. Methods: Using publicly available genetic data, we conducted Mendelian randomization (MR) analysis using the inverse variance weighting method to explore the causal relationship between 83 CVD‐related plasma proteins and PD. Various MR analysis models were employed for sensitivity analysis. Concurrently, we utilized bioinformatics methods such as protein–protein interaction networks and pathway enrichment analysis to investigate the potential associations between CVD‐related plasma proteins and PD‐related genes. Finally, we employed a mediator MR design to identify the mediating effects of 731 immune cell phenotypes in the onset of PD. Results: Elevated levels of Fas cell surface death receptors ( p = 0.015) and nerve growth factor ( p = 0.026) are associated with a reduced risk of PD, while increased levels of thrombomodulin ( p = 0.028) are a risk factor for PD. Four immune phenotypes play a significant mediating role in the association between CVD‐related proteins and the pathogenesis of PD. Sensitivity analysis indicates that the results are robust. Conclusions: Our study elucidates the close genetic association between CVD‐related plasma proteins and PD and identifies the significant mediating role of immune cells, thereby providing valuable insights for future research and clinical applications.
- 1 March 2018
- Published by Elsevier in Clinica Chimica Acta
- Vol. 478, 157-161
Serum levels of endocan and endoglin are associated with large-artery atherosclerotic stroke
- 1 March 2018
- Published by Elsevier in Clinica Chimica Acta
- Vol. 478, 157-161
Serum levels of endocan and endoglin are associated with large-artery atherosclerotic stroke
- 1 October 2016
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 83, 257-264
Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPARγ-LXRα-ABCA1/ABCG1 pathway
- 1 October 2016
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 83, 257-264
Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPARγ-LXRα-ABCA1/ABCG1 pathway